Welcome to Anagrammer Crossword Genius! Keep reading below to see if methylphenidat is an answer to any crossword puzzle or word game (Scrabble, Words With Friends etc). Scroll down to see all the info we have compiled on methylphenidat.
methylphenidat
Searching in Crosswords ...
The answer METHYLPHENIDAT has 0 possible clue(s) in existing crosswords.
Searching in Word Games ...
The word METHYLPHENIDAT is NOT valid in any word game. (Sorry, you cannot play METHYLPHENIDAT in Scrabble, Words With Friends etc)
There are 14 letters in METHYLPHENIDAT ( A1D2E1H4I1L1M3N1P3T1Y4 )
To search all scrabble anagrams of METHYLPHENIDAT, to go: METHYLPHENIDAT?
Rearrange the letters in METHYLPHENIDAT and see some winning combinations
Scrabble results that can be created with an extra letter added to METHYLPHENIDAT
10 letters out of METHYLPHENIDAT
9 letters out of METHYLPHENIDAT
8 letters out of METHYLPHENIDAT
7 letters out of METHYLPHENIDAT
6 letters out of METHYLPHENIDAT
5 letters out of METHYLPHENIDAT
4 letters out of METHYLPHENIDAT
3 letters out of METHYLPHENIDAT
2 letters out of METHYLPHENIDAT
Searching in Dictionaries ...
Definitions of methylphenidat in various dictionaries:
METHYLPHENIDAT - Methylphenidate, sold under various trade names, Ritalin being one of the most commonly known, is a central nervous system (CNS) stimulant of the phe...
Word Research / Anagrams and more ...
Keep reading for additional results and analysis below.
Methylphenidat might refer to |
---|
Methylphenidate, sold under various trade names, Ritalin being one of the most commonly known, is a central nervous system (CNS) stimulant of the phenethylamine and piperidine classes that is used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. The original patent was owned by CIBA, now Novartis Corporation. It was first licensed by the US Food and Drug Administration (FDA) in 1955 for treating what was then known as hyperactivity. * Medical use began in 1960; the drug has become increasingly prescribed since the 1990s, when the diagnosis of ADHD became more widely accepted. Between 2007 and 2012, methylphenidate prescriptions increased by 50% in the United Kingdom and in 2013 global methylphenidate consumption increased to 2.4 billion doses, a 66% increase from the year before. The United States continues to account for more than 80% of global consumption.ADHD and other similar conditions are believed to be linked to sub-par performance of the dopamine and norepinephrine functions in the brain, primarily in the prefrontal cortex, responsible for executive function (e.g., reasoning, inhibiting behaviors, organizing, problem solving, planning, etc.). Methylphenidate's mechanism of action involves the inhibition of catecholamine reuptake, primarily as a dopamine reuptake inhibitor. Methylphenidate acts by blocking the dopamine transporter and norepinephrine transporter, leading to increased concentrations of dopamine and norepinephrine within the synaptic cleft. This effect in turn leads to increased neurotransmission of dopamine and norepinephrine. Methylphenidate is also a weak 5HT1A receptor agonist. |